Building predictive models for mechanism-of-action classification from phenotypic assay data sets.

Abstract excerpt

Compound mechanism-of-action information can be critical for drug development decisions but is often challenging for phenotypic drug discovery programs. One concern is that compounds selected by phenotypic screening will have a previously known but undesirable target mechanism. Here we describe a useful method for assigning mechanism class to compounds and bioactive agents using an 84-feature signature from a...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Computer Simulation
• Share to Drug Evaluation, Preclinical
• Share to Enzyme Inhibitors